Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose Response in the Subthreshold Nanosecond Laser Trial in Early Stages of AMD: A LEAD Study Report.
Cohn AC, Runciman J, Hodgson LAB, Caruso E, Arnold JJ, Chen FK, Chakravarthy U, Heriot WJ, Guymer RH, Wu Z; LEAD Study Group. Cohn AC, et al. Among authors: arnold jj. Ophthalmic Surg Lasers Imaging Retina. 2021 Jul;52(7):380-386. doi: 10.3928/23258160-20210628-04. Epub 2021 Jul 1. Ophthalmic Surg Lasers Imaging Retina. 2021. PMID: 34309427 Clinical Trial.
Age related macular degeneration.
Arnold JJ, Heriot W. Arnold JJ, et al. BMJ Clin Evid. 2007 Apr 1;2007:0701. BMJ Clin Evid. 2007. PMID: 19454069 Free PMC article. Review.
Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes.
Gillies MC, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Hunyor AP, Essex RW, Morlet N, Barthelmes D; Fight Retinal Blindness! Project Investigators. Gillies MC, et al. Among authors: arnold jj. Invest Ophthalmol Vis Sci. 2013 Aug 27;54(8):5754-60. doi: 10.1167/iovs.13-11993. Invest Ophthalmol Vis Sci. 2013. PMID: 23821201 Free article.
Intravitreal therapy in bilateral neovascular age-related macular degeneration.
Barthelmes D, Walton RJ, Arnold JJ, McAllister IL, Simpson JM, Campain A, Hunyor AP, Guymer R, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Among authors: arnold jj. Ophthalmology. 2014 Oct;121(10):2073-4. doi: 10.1016/j.ophtha.2014.05.007. Epub 2014 Jun 14. Ophthalmology. 2014. PMID: 24939512 Free article. No abstract available.
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.
Barthelmes D, Walton R, Campain AE, Simpson JM, Arnold JJ, McAllister IL, Guymer RH, Hunyor AP, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Among authors: arnold jj. Br J Ophthalmol. 2015 Mar;99(3):359-64. doi: 10.1136/bjophthalmol-2014-305514. Epub 2014 Sep 23. Br J Ophthalmol. 2015. PMID: 25249615 Free article.
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab.
Gillies MC, Campain A, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Hunyor AP, Essex RW, Morlet N, Barthelmes D; Fight Retinal Blindness Study Group. Gillies MC, et al. Among authors: arnold jj. Ophthalmology. 2015 Mar;122(3):589-594.e1. doi: 10.1016/j.ophtha.2014.10.001. Epub 2014 Nov 6. Ophthalmology. 2015. PMID: 25458197
228 results